article lung carcinomas lung tumors lung tumor lung cancer chest x-ray showing tumor lung marked arrow classification external resources specialty oncology icd-10 c33-c34 icd-9-cm 162 omim 211980 diseasesdb 7616 medlineplus 007194 emedicine med1333 med1336 emerg335 radio807 radio405 radio406 patient uk lung cancer mesh d002283 edit wikidata lung cancer known lung carcinoma1 malignant lung tumor characterized uncontrolled cell growth tissues lung2 left untreated growth spread lung process metastasis nearby tissue parts body3 cancers start lung known primary lung cancers carcinomas4 main types small-cell lung carcinoma sclc non-small-cell lung carcinoma nsclc5 common symptoms coughing including coughing blood weight loss shortness breath chest pains6 vast majority 85 cases lung cancer due long-term tobacco smoking7 1015 cases occur people smoked8 cases caused combination genetic factors exposure radon gas asbestos second-hand smoke forms air pollution791011 lung cancer seen chest radiographs computed tomography ct scans1 diagnosis confirmed biopsy performed bronchoscopy ct-guidance1213 prevention avoiding risk factors including smoking air pollution14 treatment long-term outcomes depend type cancer stage degree spread persons health1 cases curable5 common treatments include surgery chemotherapy radiotherapy1 nsclc treated surgery sclc responds chemotherapy radiotherapy15 worldwide 2012 lung cancer occurred 1.8 million people resulted 1.6 million deaths4 makes common cancer-related death men common women breast cancer16 common age diagnosis 70 years 17.4 people united states diagnosed lung cancer survive years diagnosis17 outcomes average worse developing world18 contents 1 signs symptoms 2 2.1 smoking 2.2 radon gas 2.3 asbestos 2.4 air pollution 2.5 genetics 2.6 3 pathogenesis 4 diagnosis 4.1 classification 4.1.1 non-small-cell lung carcinoma 4.1.2 small-cell lung carcinoma 4.1.3 4.2 metastasis 4.3 staging 5 prevention 5.1 smoking ban 5.2 screening 5.3 prevention strategies 6 management 6.1 surgery 6.2 radiotherapy 6.3 chemotherapy 6.3.1 targeted therapy 6.4 bronchoscopy 6.5 palliative care 7 prognosis 8 epidemiology 9 history 10 research directions 11 references 12 external links signs symptomsedit signs symptoms suggest lung cancer include6 respiratory symptoms coughing coughing blood wheezing shortness breath systemic symptoms weight loss weakness fever clubbing fingernails symptoms due cancer mass pressing adjacent structures chest pain bone pain superior vena cava obstruction difficulty swallowing cancer grows airways obstruct airflow causing breathing difficulties obstruction lead accumulation secretions blockage predispose pneumonia6 depending type tumor paraneoplastic phenomenasymptoms due local presence cancermay initially attract attention disease19 lung cancer phenomena include hypercalcemia syndrome inappropriate antidiuretic hormone siadh abnormally concentrated urine diluted blood ectopic acth production lamberteaton myasthenic syndrome muscle weakness due autoantibodies tumors top lung known pancoast tumors invade local part sympathetic nervous system leading horners syndrome dropping eyelid small pupil side damage brachial plexus6 symptoms lung cancer poor appetite weight loss fever fatigue specific12 people cancer spread original site time symptoms seek medical attention20 symptoms suggest presence metastatic disease include weight loss bone pain neurological symptoms headaches fainting convulsions limb weakness6 common sites spread include brain bone adrenal glands opposite lung liver pericardium kidneys20 10 people lung cancer symptoms diagnosis cancers incidentally found routine chest radiography13 causesedit graph showing general increase sales tobacco products usa decades 20th century cigarettes person year led rapid increase rate lung cancer 1930s 40s 50s lung cancer deaths 100,000 male population year risk death lung cancer strongly correlated smoking cancer develops genetic damage dna epigenetic affect normal functions cell including cell proliferation programmed cell death apoptosis dna repair damage accumulates risk cancer increases21 smokingedit smoking cigarettes main contributor lung cancer22 cigarette smoke 73 known carcinogens23 including benzoapyrene24 nnk 1,3-butadiene radioactive isotope polonium polonium-21023 developed world 90 lung cancer deaths men year 2000 attributed smoking 70 women25 smoking accounts 85 lung cancer cases1 passive smokingthe inhalation smoke anothers smokingis lung cancer nonsmokers passive smoker defined living working smoker studies us262728 europe29 uk30 consistently shown significantly increased risk exposed passive smoke31 live smokes 2030 increase risk work environment secondhand smoke 1619 increase risk32 investigations sidestream smoke suggest dangerous direct smoke33 passive smoking 3,400 deaths lung cancer year usa28 marijuana smoke carcinogens tobacco smoke34 effect smoking cannabis lung cancer risk clear3536 2013 review find increased risk light moderate use37 2014 review found smoking cannabis doubled risk lung cancer38 radon gasedit radon colourless odorless gas generated breakdown radioactive radium turn decay product uranium found earths crust radiation decay products ionize genetic material causing mutations turn cancerous radon second-most common lung cancer usa39 causing 21,000 deaths year40 risk increases 816 100 bqm increase radon concentration41 radon gas levels vary locality composition underlying soil rocks 15 homes radon levels recommended guideline 4 picocuries liter pcil 148 bqm42 asbestosedit asbestos variety lung diseases including lung cancer tobacco smoking asbestos synergistic effect formation lung cancer10 smokers work asbestos risk lung cancer increased 45-fold compared general population43 asbestos cancer pleura called mesothelioma lung cancer44 air pollutionedit outdoor air pollutants especially chemicals released burning fossil fuels increase risk lung cancer7 fine particulates pm25 sulfate aerosols released traffic exhaust fumes slightly increased risk745 nitrogen dioxide incremental increase 10 parts billion increases risk lung cancer 14.46 outdoor air pollution estimated account 12 lung cancers7 tentative evidence supports increased risk lung cancer indoor air pollution related burning wood charcoal dung crop residue cooking heating47 women exposed indoor coal smoke risk number by-products burning biomass known suspected carcinogens48 risk affects 2.4billion people globally47 believed account 1.5 lung cancer deaths48 geneticsedit 8 lung cancer due inherited factors49 relatives people lung cancer risk doubled likely due combination genes50 polymorphisms chromosomes 5 6 15 known affect risk lung cancer51 causesedit numerous substances occupations environmental exposures linked lung cancer international agency research cancer iarc states sufficient evidence show carcinogenic lungs52 metals aluminum production cadmium cadmium compounds chromiumvi compounds beryllium beryllium compounds iron steel founding nickel compounds arsenic inorganic arsenic compounds underground hematite mining products combustion incomplete combustion coal indoor emissions household coal burning coal gasification coal-tar pitch coke production soot diesel engine exhaust ionizing radiation x-radiation gamma radiation plutonium toxic gases methyl ether technical grade bis-chloromethyl ether sulfur mustard mopp vincristine-prednisone-nitrogen mustard-procarbazine mixture fumes painting rubber production crystalline silica dust pathogenesisedit carcinogenesis false-color scanning electron micrograph lung cancer cell dividing similar cancers lung cancer initiated activation oncogenes inactivation tumor suppressor genes53 carcinogens mutations genes induce development cancer54 mutations k-ras proto-oncogene responsible 1030 lung adenocarcinomas5556 4 non-small-cell lung carcinomas involve eml4-alk tyrosine kinase fusion gene57 epigenetic changessuch alteration dna methylation histone tail modification microrna regulationmay lead inactivation tumor suppressor genes58 epidermal growth factor receptor egfr regulates cell proliferation apoptosis angiogenesis tumor invasion55 mutations amplification egfr common non-small-cell lung carcinoma provide basis treatment egfr-inhibitors her2neu affected frequently55 genes mutated amplified c-met nkx2-1 lkb1 pik3ca braf55 cell lines origin fully understood6 mechanism involve abnormal activation stem cells proximal airways stem cells express keratin 5 likely affected typically leading squamous-cell lung carcinoma middle airways implicated stem cells include club cells neuroepithelial cells express club cell secretory protein small-cell lung carcinoma derived cell lines59 neuroendocrine cells6 express cd4459 metastasis lung cancer requires transition epithelial mesenchymal cell type occur activation signaling pathways aktgsk3beta mek-erk fas par660 diagnosisedit ct scan showing cancerous tumor left lung performing chest radiograph investigative steps person reports symptoms suggest lung cancer reveal obvious mass widening mediastinum suggestive spread lymph nodes atelectasis collapse consolidation pneumonia pleural effusion1 ct imaging typically provide information type extent disease bronchoscopy ct-guided biopsy sample tumor histopathology13 lung cancer appears solitary pulmonary nodule chest radiograph differential diagnosis wide diseases give appearance including metastatic cancer hamartomas infectious granulomas tuberculosis histoplasmosis coccidioidomycosis61 lung cancer incidental finding solitary pulmonary nodule chest radiograph ct scan unrelated reason62 definitive diagnosis lung cancer based histological examination suspicious tissue6 context clinical radiological features12 clinical practice guidelines recommend frequencies pulmonary nodule surveillance63 ct imaging longer frequently extended surveillance exposes people increased radiation63 classificationedit pie chart showing incidences non-small cell lung cancers compared small cell carcinoma shown fractions smokers versus non-smokers shown type64 age-adjusted incidence lung cancer histological type7 histological type incidence 100,000 year types 66.9 adenocarcinoma 22.1 squamous-cell carcinoma 14.4 small-cell carcinoma 9.8 lung cancers classified according histological type12 classification important determining management predicting outcomes disease lung cancers carcinomasmalignancies arise epithelial cells lung carcinomas categorized size appearance malignant cells seen histopathologist microscope therapeutic purposes broad classes distinguished non-small-cell lung carcinoma small-cell lung carcinoma65 non-small-cell lung carcinomaedit micrograph squamous-cell carcinoma type non-small-cell carcinoma fna specimen pap stain main subtypes nsclc adenocarcinoma squamous-cell carcinoma large-cell carcinoma6 nearly 40 lung cancers adenocarcinoma originates peripheral lung tissue12 cases adenocarcinoma smoking adenocarcinoma common form lung cancer people smoked fewer 100 cigarettes lifetimes never-smokers666 ex-smokers modest smoking history6 subtype adenocarcinoma bronchioloalveolar carcinoma common female never-smokers long-term survival67 squamous-cell carcinoma accounts 30 lung cancers typically occur close large airways hollow cavity cell death commonly found center tumor12 9 lung cancers large-cell carcinoma named cancer cells large excess cytoplasm large nuclei conspicuous nucleoli12 small-cell lung carcinomaedit small-cell lung carcinoma microscopic view core needle biopsy small-cell lung carcinoma sclc cells dense neurosecretory granules vesicles neuroendocrine hormones give tumor endocrineparaneoplastic syndrome association68 cases arise larger airways primary secondary bronchi13 sixty seventy percent extensive disease targeted single radiation therapy field presentation6 othersedit main histological subtypes recognised cancers combination subtypes65 adenosquamous carcinoma12 rare subtypes include carcinoid tumors bronchial gland carcinomas sarcomatoid carcinomas12 metastasisedit typical napsin-a ttf-1 immunostaining primary lung carcinoma6 histological type napsin-a ttf-1 squamous-cell carcinoma negative negative adenocarcinoma positive positive small-cell carcinoma negative positive lung common place spread tumors parts body secondary cancers classified site origin breast cancer spread lung called metastatic breast cancer metastases characteristic round appearance chest radiograph69 primary lung cancers commonly metastasize brain bones liver adrenal glands12 immunostaining biopsy helpful determine original source70 presence napsin-a ttf-1 ck7 ck20 helpful confirming subtype lung carcinoma sclc derived neuroendocrine cells express cd56 neural cell adhesion molecule synaptophysin chromogranin6 stagingedit lung cancer staging lung cancer staging assessment degree spread cancer original source71 factors affecting prognosis potential treatment lung cancer671 evaluation non-small-cell lung carcinoma nsclc staging tnm classification based size primary tumor lymph node involvement distant metastasis6 tnm classification lung cancer672 primary tumor tx primary tumor assessed tumor cells present sputum bronchial washing tumor seen imaging bronchoscopy t0 evidence primary tumor tis carcinoma situ t1 tumor size equal 3cm surrounded lung visceral pleura invasion proximal lobar bronchus t1a tumor size equal 2cm t1b tumor size 2cm equal 3cm t2 tumor size 3cm equal 7cm involvement main bronchus 2cm distal carina invasion visceral pleura atelectasisobstructive pneumonitis extending hilum involving lung t2a tumor size 3cm equal 5cm t2b tumor size 5cm equal 7cm t3 tumor size 7cm invasion chest wall diaphragm phrenic nerve mediastinal pleura parietal pericardium tumor 2cm distal carina involving carina atelectasisobstructive pneumonitis lung separate tumor nodule lobe t4 invasion mediastinum heart great vessels trachea carina recurrent laryngeal nerve esophagus vertebra separate tumor nodule lobe lung lymph nodes nx regional lymph nodes assessed n0 regional lymph node metastasis n1 metastasis ipsilateral peribronchial andor hilar lymph nodes n2 metastasis ipsilateral mediastinal andor subcarinal lymph nodes n3 metastasis scalene supraclavicular lymph nodes metastasis contralateral hilar mediastinal lymph nodes metastasis mx distant metastasis assessed m0 distant metastasis m1a separate tumor nodule lung tumor pleural nodules malignant pleural pericardial effusion m1b distant metastasis tnm descriptors group assigned ranging occult cancer stages 0 ia one-a ib iia iib iiia iiib iv stage group assists choice treatment estimation prognosis73 stage group according tnm classification lung cancer6 tnm stage group t1at1b n0 m0 ia t2a n0 m0 ib t1at2a n1 m0 iia t2b n0 m0 t2b n1 m0 iib t3 n0 m0 t1at3 n2 m0 iiia t3 n1 m0 t4 n0n1 m0 n3 m0 iiib t4 n2 m0 m1 iv small-cell lung carcinoma sclc traditionally classified limited stage confined one-half chest scope single tolerable radiotherapy field extensive stage widespread disease6 tnm classification grouping estimating prognosis73 nsclc sclc general types staging evaluations clinical staging surgical staging clinical staging performed prior definitive surgery based results imaging studies ct scans pet scans biopsy results surgical staging evaluated operation based combined results surgical clinical findings including surgical sampling thoracic lymph nodes12 diagrams main features staging stage ia ib lung cancer stage iia lung cancer stage iib lung cancer option stage iib lung cancer t2b tumor 2cm carina stage 3 stage iiia lung cancer stage iiia lung cancer feature list side stage iiia lung cancer stage iiib lung cancer stage iiib lung cancer stage iv lung cancer preventionedit cross section human lung white area upper lobe cancer black areas discoloration due smoking smoking prevention smoking cessation effective ways preventing development lung cancer74 smoking banedit smoking ban countries industrial domestic carcinogens identified banned tobacco smoking widespread eliminating tobacco smoking primary goal prevention lung cancer smoking cessation important preventive tool process75 policy interventions decrease passive smoking public areas restaurants workplaces common western countries76 bhutan complete smoking ban 200577 india introduced ban smoking public october 2008.78 world health organization called governments institute total ban tobacco advertising prevent young people taking smoking assess bans reduced tobacco consumption 16 instituted79 screeningedit main article lung cancer screening cancer screening medical tests detect disease large groups people symptoms80 individuals high risk developing lung cancer computed tomography ct screening detect cancer give person options respond prolongs life6381 form screening reduces chance death lung cancer absolute amount 0.3 relative amount 20.8283 high risk people age 55-74 smoked equivalent amount pack cigarettes daily 30 years including time past 15 years63 ct screening high rate falsely positive tests result unneeded treatment84 true positive scan 19 falsely positives scans85 concerns include radiation exposure84 cost testing follow up63 research found testssputum cytology chest radiograph cxr screening teststo benefit8186 united states preventive services task force uspstf recommends yearly screening low-dose computed tomography total smoking history 30 pack-years 55 80 years person smoking 15 years87 screening health problems make treatment lung cancer found option87 english national health service 2014 re-examining evidence screening88 prevention strategiesedit long-term supplemental vitamin a8990 vitamin c89 vitamin d91 vitamin e89 reduce risk lung cancer studies suggest people eat diets higher proportion vegetables fruit tend lower risk2892 due confoundingwith lower risk actually due association high fruitvegetables diet smoking93 rigorous studies demonstrated clear association diet lung cancer risk692 managementedit main article treatment lung cancer treatment lung cancer depends cancers specific cell type spread persons performance status common treatments include palliative care94 surgery chemotherapy radiation therapy6 targeted therapy lung cancer growing importance advanced lung cancer surgeryedit main article lung cancer surgery pneumonectomy specimen squamous-cell carcinoma seen white area bronchi investigations confirm nsclc stage assessed determine disease localized amenable surgery spread point cured surgically ct scan positron emission tomography determination6 mediastinal lymph node involvement suspected nodes sampled assist staging techniques include transthoracic needle aspiration transbronchial needle aspiration endobronchial ultrasound endoscopic ultrasound needle aspiration mediastinoscopy thoracoscopy95 blood tests pulmonary function testing assess person surgery13 pulmonary function tests reveal poor respiratory reserve surgery possible6 cases early-stage nsclc removal lobe lung lobectomy surgical treatment choice people unfit full lobectomy smaller sublobar excision wedge resection performed wedge resection higher risk recurrence lobectomy radioactive iodine brachytherapy margins wedge excision reduce risk recurrence rarely removal lung pneumonectomy performed96 video-assisted thoracoscopic surgery vats vats lobectomy minimally invasive approach lung cancer surgery97 vats lobectomy equally effective compared conventional open lobectomy postoperative illness98 sclc chemotherapy andor radiotherapy typically used99 role surgery sclc reconsidered surgery improve outcomes added chemotherapy radiation early stage sclc100 radiotherapyedit radiotherapy chemotherapy curative intent people nsclc eligible surgery form high-intensity radiotherapy called radical radiotherapy101 refinement technique continuous hyperfractionated accelerated radiotherapy chart high dose radiotherapy short time period102 postoperative thoracic radiotherapy generally curative intent surgery nsclc103 people mediastinal n2 lymph node involvement benefit post-operative radiotherapy104 potentially curable sclc cases chest radiotherapy recommended addition chemotherapy12 internal radiotherapy lung cancer airway cancer growth blocks short section bronchus brachytherapy localized radiotherapy directly inside airway open passage compared external beam radiotherapy brachytherapy reduction treatment time reduced radiation exposure healthcare staff105 evidence brachytherapy external beam radiotherapy106 prophylactic cranial irradiation pci type radiotherapy brain reduce risk metastasis pci sclc limited-stage disease pci increases three-year survival 15 20 extensive disease one-year survival increases 13 27.107 recent improvements targeting imaging led development stereotactic radiation treatment early-stage lung cancer form radiotherapy high doses delivered number sessions stereotactic targeting techniques primarily patients surgical candidates due medical comorbidities108 nsclc sclc patients smaller doses radiation chest symptom control palliative radiotherapy109 chemotherapyedit chemotherapy regimen depends tumor type12 small-cell lung carcinoma sclc early stage disease treated primarily chemotherapy radiation110 sclc cisplatin etoposide commonly used111 combinations carboplatin gemcitabine paclitaxel vinorelbine topotecan irinotecan used112113 advanced non-small cell lung carcinoma nsclc chemotherapy improves survival first-line treatment provided person treatment114 typically drugs platinum-based cisplatin carboplatin commonly drugs gemcitabine paclitaxel docetaxel115116 pemetrexed117 etoposide vinorelbine116 adjuvant chemotherapy refers chemotherapy apparently curative surgery improve outcome nsclc samples nearby lymph nodes surgery assist staging stage ii iii disease confirmed adjuvant chemotherapy improves survival 5 years118119 combination vinorelbine cisplatin effective older regimens119 adjuvant chemotherapy people stage ib cancer controversial clinical trials clearly demonstrated survival benefit120121 chemotherapy surgery nsclc removed surgically appears improve outcomes122 chemotherapy combined palliative care treatment nsclc advanced cases chemotherapy improves average survival supportive care improving quality life123 adequate physical fitness maintaining chemotherapy lung cancer palliation offers 1.5 3 months prolongation survival symptomatic relief improvement quality life results seen modern agents124125 nsclc meta-analyses collaborative group recommends recipient wants tolerate treatment chemotherapy considered advanced nsclc114126 targeted therapyedit drugs target molecular pathways lung cancer especially treatment advanced disease erlotinib gefitinib afatinib inhibit tyrosine kinase epidermal growth factor receptor denosumab monoclonal antibody directed receptor activator nuclear factor kappa-b ligand treatment bone metastases127 bronchoscopyedit treatments administered bronchoscopy management airway obstruction bleeding airway obstructed cancer growth options include rigid bronchoscopy balloon bronchoplasty stenting microdebridement128 laser photosection involves delivery laser light inside airway bronchoscope remove obstructing tumor129 palliative careedit palliative care added usual cancer care benefits people receiving chemotherapy130 approaches allow additional discussion treatment options provide opportunities arrive well-considered decisions131132 palliative care avoid unhelpful expensive care end life course illness individuals advanced disease hospice care appropriate13132 prognosisedit outcomes lung cancer according clinical stage73 clinical stage five-year survival non-small-cell lung carcinoma small-cell lung carcinoma ia 50 38 ib 47 21 iia 36 38 iib 26 18 iiia 19 13 iiib 7 9 iv 2 1 people lung cancer 16.8 survive years diagnosis17133 england 2005 2009 five-year survival lung cancer 10.134 outcomes generally worse developing world18 stage advanced time diagnosis presentation 3040 cases nsclc stage iv 60 sclc stage iv12 survival lung cancer falls stage diagnosis advanced english data suggest 70 patients survive year diagnosed earliest stage falls 14 diagnosed advanced disease135 prognostic factors nsclc include presence pulmonary symptoms large tumor size 3cm nonsquamous cell type histology degree spread stage metastases multiple lymph nodes vascular invasion people inoperable disease outcomes worse poor performance status weight loss 10.136 prognostic factors small cell lung cancer include performance status gender stage disease involvement central nervous system liver time diagnosis137 nsclc prognosis achieved complete surgical resection stage ia disease 70 five-year survival138 people extensive-stage sclc average five-year survival rate 1 average survival time limited-stage disease 20 months five-year survival rate 20.1 according data provided national cancer institute median age diagnosis lung cancer united states 70 years139 median age death 72 years140 people medical insurance likely outcome141 epidemiologyedit trachea bronchus lung cancers deaths million person 2012 0-7 8-12 13-32 33-53 54-81 82-125 126-286 287-398 399-527 528-889 lung cancer distribution white males united states lung cancer incidence mortality survival england 19712011 worldwide lung cancer common cancer men terms incidence mortality women highest incidence breast cancer mortality 2012 1.82 million cases globally 1.56 million deaths due lung cancer representing 19.4 deaths cancer16 highest rates north america europe east asia cases 2012 china rates africa south asia lower142 population segment likely develop lung cancer people aged 50 history smoking contrast mortality rate men began declining 20 years ago womens lung cancer mortality rates rising decades recently beginning stabilize143 usa lifetime risk developing lung cancer 8 men 6 women6 34 million cigarettes smoked lung cancer death occurs144 influence big tobacco plays significant role smoking culture145 young nonsmokers tobacco advertisements likely take smoking146 role passive smoking increasingly recognized risk factor lung cancer31 leading policy interventions decrease undesired exposure nonsmokers tobacco smoke147 united states black men women higher incidence148 lung cancer rates lower developing countries149 increased smoking developing countries rates expected increase years notably china150 india151 united states military veterans 25-50 higher rate lung cancer primarily due higher rates smoking152 world war korean war asbestos played part agent orange caused problems vietnam war153 lung cancer common cancer uk 43,500 people diagnosed disease 2011 common cancer death 35,400 people died 2012.154 1960s rates lung adenocarcinoma started rise relative types lung cancer partly due introduction filter cigarettes filters removes larger particles tobacco smoke reducing deposition larger airways smoker inhale deeply receive amount nicotine increasing particle deposition small airways adenocarcinoma tends arise155 incidence lung adenocarcinoma continues rise156 historyedit timeline lung cancer lung cancer uncommon advent cigarette smoking recognized distinct disease 1761.157 aspects lung cancer 1810.158 malignant lung tumors made 1 cancers seen autopsy 1878 risen 1015 early 1900s.159 case reports medical literature numbered 374 worldwide 1912,160 review autopsies showed incidence lung cancer increased 0.3 1852 5.66 1952.161 germany 1929 physician fritz lickint recognized link smoking lung cancer159 led aggressive antismoking campaign162 british doctors study published 1950s solid epidemiological evidence link lung cancer smoking163 result 1964 surgeon general united states recommended smokers stop smoking164 connection radon gas recognized miners ore mountains schneeberg saxony silver mined 1470 mines rich uranium accompanying radium radon gas165 miners developed disproportionate amount lung disease eventually recognized lung cancer 1870s.166 despite discovery mining continued 1950s due ussrs demand uranium165 radon confirmed lung cancer 1960s.167 successful pneumonectomy lung cancer performed 1933.168 palliative radiotherapy 1940s.169 radical radiotherapy initially 1950s attempt larger radiation doses patients early-stage lung cancer unfit surgery170 1997 continuous hyperfractionated accelerated radiotherapy seen improvement conventional radical radiotherapy171 small-cell lung carcinoma initial attempts 1960s surgical resection172 radical radiotherapy173 unsuccessful 1970s successful chemotherapy regimens developed174 research directionsedit research directions lung cancer treatment include immunotherapy175 encourages bodys immune system attack tumor cells epigenetics combinations chemotherapy radiotherapy treatments work immune checkpoint blockade disrupting cancers ability evade immune system175 ipilimumab blocks signaling receptor cells known ctla-4 dampens immune system approved food drug administration fda treatment melanoma undergoing clinical trials non-small cell lung cancer nsclc small cell lung cancer sclc175 immunotherapy treatments interfere binding programmed cell death 1 pd-1 protein ligand pd-1 ligand 1 pd-l1 signaling pd-1 inactivates cells cancer cells exploit expressing pd-l1 order switch cells recognise threat monoclonal antibodies targeting pd-1 pd-l1 pembrolizumab nivolumab176 clinical trials treatment lung cancer175 epigenetics study small heritable molecular modificationsor tagsthat bind dna modify gene expression levels targeting tags drugs kill cancer cells early-stage research nsclc drugs aimed epigenetic modifications shows blocking tags kill cancer cells fewer side effects177 studies show giving patients drugs standard treatment improve effectiveness clinical trials underway evaluate drugs kill lung cancer cells humans177 drugs target epigenetic mechanisms development histone deacetylase inhibitors development include valproic acid vorinostat belinostat panobinostat entinostat romidepsin dna methyltransferase inhibitors development include decitabine azacytidine hydralazine58 tracerx project looking nsclc develops evolves tumors resistant treatment178 project look tumor samples 850 nsclc patients stages including diagnosis treatment post-treatment relapse179 studying samples points tumor development researchers hope identify drive tumor growth resistance treatment results project help scientists doctors gain understanding nsclc potentially lead development treatments disease178 lung cancer cases develop resistance epidermal growth factor receptor egfr anaplastic lymphoma kinase alk tyrosine kinase inhibitors drugs development egfr inhibitors include afatinib dacomitinib alternative signaling pathway c-met inhibited tivantinib onartuzumab alk inhibitors include crizotinib ceritinib180 referencesedit lung carcinoma tumors lungs merck professional edition online edition retrieved 15 august 2007 non-small cell lung cancer treatment patient version pdq nci 12 2015 retrieved 5 march 2016 falk williams 2010 chapter 1 lung cancerthe facts 3rd ed oxford university press pp34 isbn978-0-19-956933-5 world cancer report 2014 world health organization 2014 ppchapter 5.1 isbn9283204298 lung cancerpatient version nci retrieved 5 march 2016 horn lovly cm johnson dh 2015 chapter 107 neoplasms lung kasper dl hauser sl jameson jl fauci longo dl loscalzo harrisons principles internal medicine 19th ed mcgraw-hill isbn978-0-07-180216-1 alberg aj brock mv samet jm 2016 52 epidemiology lung cancer murray nadels textbook respiratory medicine 6th ed saunders elsevier isbn978-1-4557-3383-5 thun mj hannan lm adams-campbell ll al september 2008 lung cancer occurrence never-smokers analysis 13 cohorts 22 cancer registry studies plos medicine 5 9 e185 doi101371journalpmed0050185 pmc2531137 pmid18788891 carmona rh 27 june 2006 health consequences involuntary exposure tobacco smoke report surgeon general department health human services secondhand smoke exposure disease premature death children adults smoke retrieved 2014-06-16 oreilly km mclaughlin beckett ws sime pj march 2007 asbestos-related lung disease american family physician 75 5 683688 pmid17375514 tobacco smoke involuntary smoking pdf iarc monographs evaluation carcinogenic risks humans international agency research cancer 83 2004 sufficient evidence involuntary smoking exposure secondhand environmental tobacco smoke lung cancer humans involuntary smoking exposure secondhand environmental tobacco smoke carcinogenic humans group 1 lu onn vaporciyan aa al 2010 78 cancer lung holland-frei cancer medicine 8th ed peoples medical publishing house isbn978-1-60795-014-1 collins lg haines perkel enck re january 2007 lung cancer diagnosis management american family physician american academy family physicians 75 1 5663 pmid17225705 lung cancer preventionpatient version pdq nci november 4 2015 retrieved 5 march 2016 chapman robinson stradling west 2009 chapter 31 oxford handbook respiratory medicine 2nd ed oxford university press isbn978-0-19-954516-2 world cancer report 2014 world health organization 2014 ppchapter 1.1 isbn9283204298 surveillance epidemiology end results program national cancer institute retrieved 5 mar 2016 majumder edited sadhan 2009 stem cells cancer online-ausg ed york springer p193 isbn978-0-387-89611-3 honnorat antoine jc 2007 paraneoplastic neurological syndromes orphanet journal rare diseases biomed central 2 1 22 doi1011861750-1172-2-22 pmc1868710 pmid17480225 greene frederick 2002 ajcc cancer staging berlin springer-verlag isbn0-387-95271-3 brown km keats jj sekulic al 2010 chapter 8 holland-frei cancer medicine 8th ed peoples medical publishing house usa isbn978-1-60795-014-1 biesalski hk bueno de mesquita chesson al 1998 european consensus statement lung cancer risk factors prevention lung cancer panel ca cancer clin smoking major risk factor accounting 90 lung cancer incidence 48 3 167176 discussion 164166 doi103322canjclin483167 pmid9594919 hecht ss 2012 lung carcinogenesis tobacco smoke international journal cancer 131 12 27242732 doi101002ijc27816 pmc3479369 pmid22945513 kumar abbas ak aster jc 2013 chapter 5 robbins basic pathology 9th ed elsevier saunders p199 isbn978-1-4377-1781-5 peto lopez ad boreham al 2006 mortality smoking developed countries 19502000 indirect estimates national vital statistics oxford university press isbn0-19-262535-7 california environmental protection agency 1997 health effects exposure environmental tobacco smoke california environmental protection agency tobacco control 6 4 346353 doi101136tc64346 pmc1759599 pmid9583639 centers disease control prevention cdc december 2001 state-specific prevalence cigarette smoking adults policies attitudes secondhand smokeunited states 2000 morbidity mortality weekly report atlanta georgia cdc 50 49 11011106 pmid11794619 alberg aj samet jm september 2007 epidemiology lung cancer chest american college chest physicians 132 s3 29s55s doi101378chest07-1347 pmid17873159 jaakkola ms jaakkola jj august 2006 impact smoke-free workplace legislation exposures health possibilities prevention european respiratory journal 28 2 397408 doi101183090319360600001306 pmid16880370 parkin dm december 2011 tobaccoattributable cancer burden uk 2010 british journal cancer 105 suppl 2 s6s13 doi101038bjc2011475 pmc3252064 pmid22158323 taylor najafi dobson october 2007 meta-analysis studies passive smoking lung cancer effects study type continent international journal epidemiology 36 5 10481059 doi101093ijedym158 pmid17690135 frequently asked questions hand smoke world health organization retrieved 25 july 2012 schick glantz december 2005 philip morris toxicological experiments fresh sidestream smoke toxic mainstream smoke tobacco control 14 6 396404 doi101136tc2005011288 pmc1748121 pmid16319363 greydanus de hawver ek greydanus mm october 2013 marijuana concepts frontiers public health 1 42 doi103389fpubh201300042 pmc3859982 pmid24350211 owen kp sutter albertson te february 2014 marijuana respiratory tract effects clinical reviews allergy immunology 46 1 6581 doi101007s12016-013-8374-y pmid23715638 joshi joshi bartter march 2014 marijuana lung diseases opinion pulmonary medicine 20 2 173179 doi101097mcp0000000000000026 pmid24384575 tashkin dp june 2013 effects marijuana smoking lung annals american thoracic society 10 3 23947 doi101513annalsats201212-127fr pmid23802821 underner urban perriot june 2014 cannabis smoking lung cancer revue des maladies respiratoires 31 6 488498 doi101016jrmr201312002 pmid25012035 choi mazzone september 2014 radon lung cancer assessing mitigating risk cleveland clinic journal medicine 81 9 567575 doi103949ccjm81a14046 pmid25183848 radon rn health risks epa schmid kuwert drexler march 2010 radon indoor spaces underestimated risk factor lung cancer environmental medicine dtsch arztebl int 107 11 1816 doi103238arztebl20100181 pmc2853156 pmid20386676 epa february 2013 radiation information radon epa tobias hochhauser 2010 chapter 12 cancer management 6th ed wiley-blackwell p199 isbn978-1405-170154 davies rjo lee ycg 2010 18.19.3 oxford textbook medicine 5th ed oup oxford isbn978-0-19-920485-4 chen goldberg ms villeneuve pj octdec 2008 systematic review relation long-term exposure ambient air pollution chronic diseases reviews environmental health 23 4 243297 doi101515reveh2008234243 pmid19235364 clapp rw jacobs mm loechler el janmar 2008 environmental occupational cancer evidence 20052007 reviews environmental health 23 1 137 doi101515reveh20082311 pmc2791455 pmid18557596 lim wy seow january 2012 biomass fuels lung cancer respirology carlton vic 17 1 2031 doi101111j1440-1843201102088x pmid22008241 sood december 2012 indoor fuel exposure lung developing developed countries update clinics chest medicine 33 4 64965 doi101016jccm201208003 pmid23153607 yang ia holloway jw fong km october 2013 genetic susceptibility lung cancer co-morbidities journal thoracic disease 5 suppl 5 s454s462 doi103978jissn2072-143920130806 pmc3804872 pmid24163739 dela cruz cs tanoue lt matthay ra 2015 chapter 109 epidemiology lung cancer grippi ma elias ja fishman ja kotloff rm pack ai senior rm fishmans pulmonary diseases disorders 5th ed mcgraw-hill p1673 isbn978-0-07-179672-9 larsen je minna december 2011 molecular biology lung cancer clinical implications clinics chest medicine 32 4 703740 doi101016jccm201108003 pmc3367865 pmid22054881 cogliano vj baan straif grosse lauby-secretan el ghissassi bouvard benbrahim-tallaa guha freeman galichet wild cp 21 december 2011 preventable exposures human cancers pdf journal national cancer institute 103 24 182739 doi101093jncidjr483 pmid22158127 cs1 maint authors parameter link cooper wa lam dlc otoole sa october 2013 molecular biology lung cancer pdf journal thoracic disease 5 suppl 5 479490 doi103978jissn2072-143920130803 pmc3804875 pmid24163741 tobias hochhauser 2010 chapter 12 cancer management 6th ed wiley-blackwell p200 isbn978-1405-170154 herbst rs heymach jv lippman sm september 2008 lung cancer england journal medicine 359 13 13671380 doi101056nejmra0802714 pmid18815398 aviel-ronen blackhall fh shepherd fa tsao ms july 2006 k-ras mutations non-small-cell lung carcinoma review clinical lung cancer cancer information group 8 1 3038 doi103816clc2006n030 pmid16870043 kumar abbas ak aster jc 2013 chapter 5 robbins basic pathology 9th ed elsevier saunders p212 isbn978-1-4377-1781-5 jakopovic thomas balasubramaniam october 2013 targeting epigenome lung cancer expanding approaches epigenetic therapy pdf frontiers oncology 3 261 doi103389fonc201300261 pmc3793201 pmid24130964 mulvihill ms kratz jr pham february 2013 role stem cells airway repair implications origins lung cancer chinese journal cancer 32 2 7174 doi105732cjc01210097 pmc3845611 pmid23114089 powell ca halmos nana-sinkam sp july 2013 update lung cancer mesothelioma 2012 pdf american journal respiratory critical care medicine 188 2 157166 doi101164rccm201304-0716up pmc3778761 pmid23855692 ost 2015 chapter 110 approach patient pulmonary nodules grippi ma elias ja fishman ja kotloff rm pack ai senior rm fishmans pulmonary diseases disorders 5th ed mcgraw-hill p1685 isbn978-0-07-179672-9 frank quint le march 2012 chest ct incidentalomas thyroid lesions enlarged mediastinal lymph nodes lung nodules cancer imaging 12 1 4148 doi1011021470-733020120006 pmc3335330 pmid22391408 american college chest physicians american thoracic society september 2013 things physicians patients question choosing wisely initiative abim foundation american college chest physicians american thoracic society retrieved 6 january 2013 smokers defined smoker 1 year duration image page commons percentages numbers reference table 2 kenfield wei stampfer rosner colditz 2008 comparison aspects smoking histological types lung cancer tobacco control 17 3 198204 doi101136tc2007022582 pmc3044470 pmid18390646 kumar abbas ak aster jc 2013 12 robbins basic pathology 9th ed elsevier saunders p505 isbn978-1-4377-1781-5 subramanian govindan february 2007 lung cancer smokers review journal clinical oncology american society clinical oncology 25 5 561570 doi101200jco2006068015 pmid17290066 raz dj rosell jablons dm march 2006 bronchioloalveolar carcinoma review clinical lung cancer 7 5 313322 doi103816clc2006n012 pmid16640802 rosti bevilacqua bidoli al march 2006 small cell lung cancer annals oncology 17 suppl 2 510 doi101093annoncmdj910 pmid16608983 seo jb im jg goo jm al 1 march 2001 atypical pulmonary metastases spectrum radiologic findings radiographics 21 2 403417 doi101148radiographics212g01mr17403 pmid11259704 tan zander ds 2008 immunohistochemistry assessment pulmonary pleural neoplasms review update int clin exp pathol 1 1 1931 pmc2480532 pmid18784820 connolly jl goldsmith jd wang hh al 2010 37 principles cancer pathology holland-frei cancer medicine 8th ed peoples medical publishing house isbn978-1-60795-014-1 chheang brown june 2013 lung cancer staging clinical radiologic perspectives seminars interventional radiology 30 2 99113 doi101055s-0033-1342950 pmc3709937 pmid24436525 rami-porta crowley jj goldstraw february 2009 revised tnm staging system lung cancer pdf annals thoracic cardiovascular surgery 15 1 49 pmid19262443 dela cruz cs tanoue lt matthay ra december 2011 lung cancer epidemiology etiology prevention pdf clinic chest medicine 32 4 605644 doi101016jccm201109001 pmc3864624 pmid22054876 goodman ge november 2002 lung cancer 1 prevention lung cancer pdf thorax 57 11 994999 doi101136thorax5711994 pmc1746232 pmid12403886 mcnabola gill lw february 2009 control environmental tobacco smoke policy review international journal environmental research public health 6 2 741758 doi103390ijerph6020741 pmc2672352 pmid19440413 pandey february 2005 bhutans smokers face public ban bbc retrieved 7 september 2007 pandey 2 october 2008 indian ban smoking public bbc retrieved 25 april 2012 un health agency calls total ban tobacco advertising protect young press release united nations news service 30 2008 gutierrez suh abtin june 2013 lung cancer screening seminars interventional radiology 30 2 114120 doi101055s-0033-1342951 pmc3709936 pmid24436526 usman ali miller peirson fitzpatrick-lewis kenny sherifali raina august 2016 screening lung cancer systematic review meta-analysis preventive medicine 89 30114 doi101016jypmed201604015 pmid27130532 jaklitsch mt jacobson fl austin jh al july 2012 american association thoracic surgery guidelines lung cancer screening low-dose computed tomography scans lung cancer survivors high-risk groups journal thoracic cardiovascular surgery 144 1 3338 doi101016jjtcvs201205060 pmid22710039 bach pb mirkin jn oliver tk al june 2012 benefits harms ct screening lung cancer systematic review jama journal american medical association 307 22 24182429 doi101001jama20125521 pmc3709596 pmid22610500 aberle abtin brown 2013 computed tomography screening lung cancer finally arrived implications national lung screening trial journal clinical oncology 31 8 10021008 doi101200jco2012433110 issn0732-183x pmid23401434 bach pb mirkin jn oliver tk al june 2012 benefits harms ct screening lung cancer systematic review jama 307 22 241829 doi101001jama20125521 pmc3709596 pmid22610500 manser lethaby irving lb stone byrnes abramson mj campbell 2013 screening lung cancer cochrane database systematic reviews 6 6 cd001991 doi10100214651858cd001991pub3 pmid23794187 cs1 maint authors parameter link moyer va preventive services task force mar 4 2014 screening lung cancer preventive services task force recommendation statement annals internal medicine 160 5 3308 doi107326m13-2771 pmid24378917 baldwin dr hansell dm duffy sw field jk mar 7 2014 lung cancer screening low dose computed tomography bmj clinical research ed 348 g1970 doi101136bmjg1970 pmid24609921 fabricius lange julyseptember 2003 diet lung cancer monaldi archives chest disease 59 3 207211 pmid15065316 fritz kennedy fergusson al 2011 vitamin retinoid derivatives lung cancer systematic review meta analysis plos 6 6 e21107 doi101371journalpone0021107 pmc3124481 pmid21738614 herr greulich koczulla ra al march 2011 role vitamin pulmonary disease copd asthma infection cancer respiratory research 12 1 31 doi1011861465-9921-12-31 pmc3071319 pmid21418564 key tj january 2011 fruit vegetables cancer risk british journal cancer 104 1 611 doi101038sjbjc6606032 pmc3039795 pmid21119663 bradbury ke appleby pn key tj june 2014 fruit vegetable fiber intake relation cancer risk findings european prospective investigation cancer nutrition epic american journal clinical nutrition 100 suppl 1 394s398s doi103945ajcn113071357 pmid24920034 ferrell koczywas grannis harrington april 2011 palliative care lung cancer surgical clinics north america 91 2 403417 doi101016jsuc201012003 pmid21419260 chang rivera mp 2015 chapter 112 clinical evaluation diagnosis staging lung cancer grippi ma elias ja fishman ja kotloff rm pack ai senior rm fishmans pulmonary diseases disorders 5th ed mcgraw-hill p1728 isbn978-0-07-179672-9 reznik si smythe wr 2015 chapter 113 treatment non-small-cell lung cancer surgery grippi ma elias ja fishman ja kotloff rm pack ai senior rm fishmans pulmonary diseases disorders 5th ed mcgraw-hill p17371738 isbn978-0-07-179672-9 alam flores rm julyseptember 2007 video-assisted thoracic surgery vats lobectomy evidence base journal society laparoendoscopic surgeons 11 3 368374 pmc3015831 pmid17931521 rueth nm andrade rs june 2010 vats lobectomy perioperatively biologically oncologically annals thoracic surgery 89 6 s2107s2111 doi101016jathoracsur201003020 pmid20493991 simon gr turrisi september 2007 management small cell lung cancer accp evidence-based clinical practice guidelines 2nd edition chest 132 3 suppl 324s339s doi101378chest07-1385 pmid17873178 goldstein sd yang sc october 2011 role surgery small cell lung cancer surgical oncology clinics north america 20 4 769777 doi101016jsoc201108001 pmid21986271 arriagada goldstraw le chevalier 2002 oxford textbook oncology 2nd ed oxford university press p2094 isbn0-19-262926-3 hatton mq martin je june 2010 continuous hyperfractionated accelerated radiotherapy chart non-conventionally fractionated radiotherapy treatment non-small cell lung cancer review consideration future directions clinical oncology royal college radiologists 22 5 356364 doi101016jclon201003010 pmid20399629 port meta-analysis trialists group 2005 rydzewska larysa ed postoperative radiotherapy non-small cell lung cancer cochrane database systematic reviews 2 cd002142 doi10100214651858cd002142pub2 pmid15846628 le pchoux 2011 role postoperative radiotherapy resected non-small cell lung cancer reassessment based data oncologist 16 5 672681 doi101634theoncologist2010-0150 pmc3228187 pmid21378080 ikushima february 2010 radiation therapy state art future journal medical investigation 57 12 111 doi102152jmi571 pmid20299738 reveiz rueda jr cardona af 12 december 2012 palliative endobronchial brachytherapy non-small cell lung cancer cochrane database systematic reviews 12 cd004284 doi10100214651858cd004284pub3 pmid23235606 paumier cuenca le pchoux june 2011 prophylactic cranial irradiation lung cancer cancer treatment reviews 37 4 261265 doi101016jctrv201008009 pmid20934256 girard mornex october 2011 stereotactic radiotherapy non-small cell lung cancer concept clinical reality 2011 update cancer radiothrapie 15 67 522526 doi101016jcanrad201107241 pmid21889901 fairchild harris barnes al august 2008 palliative thoracic radiotherapy lung cancer systematic review journal clinical oncology 26 24 40014011 doi101200jco2007153312 pmid18711191 hann cl rudin cm 30 november 2008 management small-cell lung cancer incremental hope future oncology williston park 22 13 148692 pmid19133604 murray turrisi march 2006 review first-line treatment small-cell lung cancer journal thoracic oncology 1 3 270278 pmid17409868 azim ha ganti ak march 2007 treatment options relapsed small-cell lung cancer anti-cancer drugs 18 3 255261 doi101097cad0b013e328011a547 pmid17264756 maccallum gillenwater hh july 2006 second-line treatment small-cell lung cancer oncology reports 8 4 258264 doi101007s11912-006-0030-8 pmid17254525 nsclc meta-analyses collaborative group october 2008 chemotherapy addition supportive care improves survival advanced nonsmall-cell lung cancer systematic review meta-analysis individual patient data 16 randomized controlled trials clin oncol 26 28 461725 doi101200jco2008177162 pmc2653127 pmid18678835 carr ll jett jr 2015 chapter 114 treatment non-small-cell lung cancer chemotherapy grippi ma elias ja fishman ja kotloff rm pack ai senior rm fishmans pulmonary diseases disorders 5th ed mcgraw-hill p1752 isbn978-0-07-179672-9 clegg scott da hewitson al january 2002 clinical cost effectiveness paclitaxel docetaxel gemcitabine vinorelbine non-small cell lung cancer systematic review thorax bmj publishing group 57 1 2028 doi101136thorax57120 pmc1746188 pmid11809985 fuld ad dragnev kh rigas jr june 2010 pemetrexed advanced non-small-cell lung cancer expert opin pharmacother 11 8 1387402 doi101517146565662010482560 pmid20446853 carbone dp felip september 2011 adjuvant therapy non-small cell lung cancer future treatment prospects paradigms clinical lung cancer 12 5 261271 doi101016jcllc201106002 pmid21831720 le chevalier october 2010 adjuvant chemotherapy resectable non-small-cell lung cancer going annals oncology 21 suppl 7 vii196198 doi101093annoncmdq376 pmid20943614 horn sandler ab putnam jb jr johnson dh 2007 rationale adjuvant chemotherapy stage non-small cell lung cancer journal thoracic oncology 2 5 377383 doi10109701jto000026866964625bb pmid17473651 wakelee ha schiller jh gandara dr july 2006 status adjuvant chemotherapy stage ib non-small-cell lung cancer implications intergroup trial clinical lung cancer cancer information group 8 1 1821 doi103816clc2006n028 pmid16870041 nsclc meta-analysis collaborative group 3 2014 preoperative chemotherapy non-small-cell lung cancer systematic review meta-analysis individual participant data lancet 383 9928 156171 doi101016s0140-67361362159-5 pmc4022989 pmid24576776 souquet pj chauvin boissel jp bernard jp april 1995 meta-analysis randomised trials systemic chemotherapy versus supportive treatment non-resectable non-small cell lung cancer lung cancer 12 suppl 1 s14754 doi1010160169-50029500430-9 pmid7551923 srenson glimelius nygren 2001 systematic overview chemotherapy effects non-small cell lung cancer acta oncologica 40 23 32739 doi10108002841860151116402 pmid11441939 clegg scott da sidhu hewitson waugh 2001 rapid systematic review clinical effectiveness cost-effectiveness paclitaxel docetaxel gemcitabine vinorelbine non-small-cell lung cancer health technology assessment 5 32 1195 pmid12065068 non-small cell lung cancer collaborative group 12 2010 chemotherapy supportive care versus supportive care advanced non-small cell lung cancer cochrane database systematic reviews 5 cd007309 doi10100214651858cd007309pub2 pmid20464750 dantonio passaro gori 2014 bone brain metastasis lung cancer recent advances therapeutic strategies therapeutic advances medical oncology 6 3 101114 doi1011771758834014521110 pmc3987652 pmid24790650 lazarus dr eapen ga 2014 chapter 16 bronchoscopic interventions lung cancer roth ja hong wk komaki ru lung cancer 4th ed wiley-blackwell isbn978-1-118-46874-6 khemasuwan mehta ac wang kp december 2015 past present future endobronchial laser photoresection journal thoracic disease 7 suppl 4 s380s388 doi103978jissn2072-143920151255 pmc4700383 pmid26807285 parikh rb kirch ra smith tj temel js 12 december 2013 early specialty palliative care--translating data oncology practice england journal medicine 369 24 234751 doi101056nejmsb1305469 pmc3991113 pmid24328469 kelley meier de august 2010 palliative carea shifting paradigm england journal medicine 363 8 7812 doi101056nejme1004139 pmid20818881 prince-paul april 2009 hospice option opportunity redefine goals oncology williston park ny 23 4 suppl nurse ed 137 pmid19856592 ridge ca mcerlean ginsberg ms june 2013 epidemiology lung cancer seminars interventional radiology 30 2 9398 doi101055s-0033-1342949 pmc3709917 pmid24436524 lung cancer survival statistics cancer research uk lung cancer survival statistics retrieved 28 october 2014 non-small cell lung cancer treatment pdq health professionals national cancer institute pmid26389304 retrieved 17 november 2015 small cell lung cancer treatment pdq health professionals national cancer institute 2012 retrieved 16 2012 spiro sg 2010 18.19.1 oxford textbook medicine 5th ed oup oxford isbn978-0-19-920485-4 seer data seercancergov median age cancer patients diagnosis 20022003 seer data seercancergov median age cancer patients death 20022006 slatore cg au dh gould mk november 2010 official american thoracic society systematic review insurance status disparities lung cancer practices outcomes american journal respiratory critical care medicine 182 9 11951205 doi101164rccm2009-038st pmid21041563 stewart edited bernard wild christopher 2014 world cancer report 2014 lyon iarc press pp350352 isbn9789283204299 jemal tiwari rc murray al 2004 cancer statistics 2004 ca cancer journal clinicians 54 1 829 doi103322canjclin5418 pmid14974761 proctor rn march 2012 history discovery cigarette-lung cancer link evidentiary traditions corporate denial global toll tobacco control 21 2 8791 doi101136tobaccocontrol-2011-050338 pmid22345227 lum kl polansky jr jackler rk glantz sa october 2008 signed sealed delivered big tobacco hollywood 19271951 tobacco control 17 5 313323 doi101136tc2008025445 pmc2602591 pmid18818225 lovato watts stead lf october 2011 impact tobacco advertising promotion increasing adolescent smoking behaviours cochrane database systematic reviews 10 cd003439 doi10100214651858cd003439pub2 pmid21975739 kemp fb julsep 2009 smoke free policies europe overview pneumologia 58 3 155158 pmid19817310 national cancer institute seer stat fact sheets lung bronchus surveillance epidemiology end results 2010 1 gender lung cancer smoking research pdf world health organization 2004 retrieved 26 2007 zhang ou jx bai cx november 2011 tobacco smoking china prevalence disease burden challenges future strategies respirology 16 8 11651172 doi101111j1440-1843201102062x pmid21910781 behera balamugesh 2004 lung cancer india pdf indian journal chest diseases allied sciences 46 4 269281 pmid15515828 honoring veterans good health november 7 2014 retrieved 1 december 2015 lung cancer affects veterans military retrieved 1 december 2015 lung cancer statistics cancer research uk retrieved 28 october 2014 charloux quoix wolkove al february 1997 increasing incidence lung adenocarcinoma reality artefact review epidemiology lung adenocarcinoma international journal epidemiology 26 1 1423 doi101093ije26114 pmid9126499 kadara kabbout wistuba ii january 2012 pulmonary adenocarcinoma renewed entity 2011 respirology 17 1 5065 doi101111j1440-1843201102095x pmid22040022 morgagni giovanni battista 1761 de sedibus causis morborum anatomen indagatis ol24830495m bayle gaspard-laurent 1810 recherches sur la phthisie pulmonaire french paris ol15355651w witschi november 2001 short history lung cancer toxicological sciences 64 1 46 doi101093toxsci6414 pmid11606795 adler 1912 primary malignant growths lungs bronchi york longmans green company oclc14783544 ol24396062m cited spiro sg silvestri ga 2005 hundred years lung cancer american journal respiratory critical care medicine 172 5 523529 doi101164rccm200504-531oe pmid15961694 grannis fw history cigarette smoking lung cancer smokinglungscom archived original 18 july 2007 retrieved 6 august 2007 proctor 2000 nazi war cancer princeton university press pp173246 isbn0-691-00196-0 doll hill ab november 1956 lung cancer death relation smoking british medical journal 2 5001 10711081 doi101136bmj250011071 pmc2035864 pmid13364389 department health education welfare 1964 smoking health report advisory committee surgeon general public health service pdf washington dc government printing office greaves 2000 cancer evolutionary legacy oxford university press pp196197 isbn0-19-262835-6 greenberg selikoff ij february 1993 lung cancer schneeberg mines reappraisal data reported harting hesse 1879 annals occupational hygiene 37 1 514 doi101093annhyg3715 pmid8460878 samet jm april 2011 radiation cancer risk continuing challenge epidemiologists environmental health 10 suppl 1 s4 doi1011861476-069x-10-s1-s4 pmc3073196 pmid21489214 horn johnson dh july 2008 evarts graham pneumonectomy lung cancer journal clinical oncology 26 19 32683275 doi101200jco2008168260 pmid18591561 edwards 1946 carcinoma bronchus thorax 1 1 125 doi101136thx111 pmc1018207 pmid20986395 kabela 1956 erfahrungen mit der radikalen rntgenbestrahlung des bronchienkrebses experience radical irradiation bronchial cancer ceskoslovensk onkolgia german 3 2 109115 pmid13383622 saunders dische barrett al july 1997 continuous hyperfractionated accelerated radiotherapy chart versus conventional radiotherapy non-small-cell lung cancer randomised multicentre trial lancet elsevier 350 9072 161165 doi101016s0140-67369706305-8 pmid9250182 lennox sc flavell pollock dj al november 1968 results resection oat-cell carcinoma lung lancet elsevier 2 7575 925927 doi101016s0140-67366891163-x pmid4176258 miller ab fox tall september 1969 five-year follow-up medical research council comparative trial surgery radiotherapy primary treatment small-celled oat-celled carcinoma bronchus lancet elsevier 2 7619 501505 doi101016s0140-67366990212-8 pmid4184834 cohen creaven pj fossieck jr al 1977 intensive chemotherapy small cell bronchogenic carcinoma cancer treatment reports 61 3 349354 pmid194691 cs1 maint authors parameter link brahmer jr february 2014 immune checkpoint blockade hope immunotherapy treatment lung cancer seminars oncology 41 1 12632 doi101053jseminoncol201312014 pmid24565586 powell ca halmos nana-sinkam sp july 2013 update lung cancer mesothelioma 2012 american journal respiratory critical care medicine 188 2 157166 doi101164rccm201304-0716up pmc3778761 pmid23855692 forde pm brahmer jr kelly rj 1 2014 strategies lung cancer epigenetic therapy non-small cell lung cancer clinical cancer research 20 9 22448 doi1011581078-0432ccr-13-2088 pmid24644000 jamal-hanjani hackshaw ngai al july 2014 tracking genomic cancer evolution precision medicine lung tracerx study plos biology 12 7 e1001906 doi101371journalpbio1001906 pmc4086714 pmid25003521 tracerx project cancer research uk science blog spaans jn goss gd august 2014 trials overcome drug resistance egfr alk targeted therapiespast present future frontiers oncology 4 233 doi103389fonc201400233 pmc4145253 pmid25221748 external linksedit wikimedia commons media related lung cancers lung cancer dmoz tumours neoplasia respiratory tract c30c34d14 160163212.0212.4 upper rt nasal cavity esthesioneuroblastoma nasopharynx nasopharyngeal carcinoma nasopharyngeal angiofibroma larynx laryngeal cancer laryngeal papillomatosis lower rt trachea tracheal tumor lung non-small-cell lung carcinoma squamous-cell carcinoma adenocarcinoma mucinous cystadenocarcinoma large-cell lung carcinoma rhabdoid carcinoma sarcomatoid carcinoma carcinoid salivary glandlike carcinoma adenosquamous carcinoma papillary adenocarcinoma giant-cell carcinoma small-cell carcinoma combined small-cell carcinoma non-carcinoma sarcoma lymphoma immature teratoma melanoma location pancoast tumor solitary pulmonary nodule central lung peripheral lung pleura mesothelioma malignant solitary fibrous tumor authority control ndl 00562782 